+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors



The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors



Nucleic Acids Research 27(22): 4369-4375



Expression of transfected genes is shown to be suppressed by two intracellular enzymes, RNase L and protein kinase PKR, which function in interferon-treated cells to restrict viral replication. RNase L(-/-) or PKR(-/-) murine embryonic fibroblasts produced enhanced levels of protein from transfected genes compared with wild-type cells. Increased expression of exogenous genes in RNase L(-/-) cells correlated with elevated levels of mRNA and thus appeared to be due to enhanced mRNA stability. Plasmid encoding adenovirus VA RNAs was able to further enhance accumulation of the exogenous gene transcript and protein, even in cells lacking PKR. In contrast to the increased expression of transfected genes in cells lacking RNase L or PKR, expression of endogenous host genes was unaffected by the absence of these enzymes. In addition, a dominant-negative PKR mutant improved expression from a conventional plasmid vector and from a Semliki Forest virus derived, self-replicating vector. These results indicate that viral infections and transfections produce similar stress responses in mammalian cells and suggest strategies for selectively increasing expression of exogenous genes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011477163

Download citation: RISBibTeXText

PMID: 10536144

DOI: 10.1093/nar/27.22.4369


Related references

Programmed gene expression in retrogradely targeted areas of the CNS by viral and non-viral vectors. Society for Neuroscience Abstracts 23(1-2): 296, 1997

Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Advanced Drug Delivery Reviews 52(3): 153-164, 2001

Expression patterns of non-viral transfection with GFP in the organ of Corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors. Hno 56(5): 524-529, 2008

Site specific genomic integration of recombinant Adeno-associated viral vectors can be achieved by co-expression of the viral rep gene. Onkologie 23(Sonderheft 7): 55, 2000

Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells. Proceedings of the National Academy of Sciences of the United States of America 107(16): 7269-7274, 2010

Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. Journal of Virology 69(1): 376-386, 1995

Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. Human Gene Therapy 15(2): 203-210, 2004

Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Molecular Therapy 4(3): 164-173, 2001

Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1. Atherosclerosis 186(1): 65-73, 2006

Evaluation of Tetracycline Response Element - Based Genetic Switches for Control of Gene Expression in Adeno- and Lentiviral Viral Vectors. FASEB Journal 18(4-5): Abst 823 5, 2004

Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. Journal of Thrombosis and Haemostasis 5(1): 16-24, 2007

Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting. Current Gene Therapy 5(1): 133-142, 2005

Viral and non-viral vectors in gene therapy: technology development and clinical trials. Technology in Cancer Research and Treatment 2(5): 471-486, 2003

Viral vectors for cancer gene therapy: viral dissemination and tumor targeting. Current Gene Therapy 5(1): 133-142, 2005

Recent advance of development of viral and non-viral vectors for gene therapy. Yakugaku Zasshi 126(11): 1011, 2006